Examinando por Autor "Ballesteros Seminario, Yulissa Ruth"
Mostrando 1 - 1 de 1
- Resultados por página
- Opciones de ordenación
Ítem Acceso abierto Critical review: nutritional management in patients with neoplasia of the head and neck undergoing chemo and/or radiotherapy treatment(Universidad Privada Norbert Wiener, 2023-12-15) Ballesteros Seminario, Yulissa Ruth; Bohórquez Medina, Sofia LorenaNutritional management is important for oncological patients as it helps keep them stable during chemotherapy and/or radiotherapy treatment. This secondary research titled: ‘CRITICAL REVIEW: NUTRITIONAL MANAGEMENT IN PATIENTS WITH HEAD AND NECK NEOPLASIA UNDER CHEMOTHERAPY OR RADIOTHERAPY TREATMENT’ aimed to determine the best nutritional management for patients with head and neck neoplasia undergoing chemotherapy or radiotherapy treatment, identify the common problems that occur before, during, and after chemotherapy and radiotherapy treatment concerning the nutritional status of cancer patients. The clinical question was: ‘What is the nutritional management for patients with head and neck neoplasia undergoing chemotherapy or radiotherapy treatment?’ The Evidence-Based Nutrition (EBN) methodology was used. Information was gathered from PubMed/MEDLINE, ScienceDirect, WOS, and SCOPUS, yielding 20 articles, with the final selection based on the ‘CASPE’ tool from the meta-analysis titled: 'Nutrition management for patients with head and neck cancer during peri-radiotherapy: A systematic review and quality appraisal of clinical practice guidelines using the AGREE II instrument.' The critical commentary concluded that there were discrepancies in existing clinical practice guidelines (CPGs), including nutritional screening, assessment, intake, nutrients, the absence of essential parts of the CPGs, the statement of external review, the method for making recommendations, strategies for improving acceptance, and the implications of resource use in applying the CPGs. Specialized CPGs should be developed for the nutritional treatment of head and neck cancer patients during radiotherapy.
